The present invention involves the use of quantitative RT-PCR to identify
AC133 as a marker. AC133 is prevalent on endothelial progenitor cells
(EPCs), which are important cells in angiogenesis. Therefore, the
invention is applied to ascertain the quantity of EPCs in a subject, and
to diagnose and monitor angiogenesis, for example, in injured tissues and
in cancer development and progression.